Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Price Target Raised to $11.00

Posted by Stanley Muller on Nov 10th, 2026

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) had its price target boosted by Barclays from $10.00 to $11.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target points to a potential downside of 14.22% from the company’s previous close.

Other equities analysts have also recently issued reports about the company. Weiss Ratings raised Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, November 4th. Mizuho reduced their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. TD Cowen reaffirmed a “buy” rating and issued a $15.00 price objective on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday, October 27th. Stifel Nicolaus restated a “hold” rating and set a $10.00 price target (up from $9.00) on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday. Finally, HC Wainwright reiterated a “buy” rating and set a $14.00 price objective on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $13.60.

View Our Latest Analysis on SENS

Senseonics Holdings, Inc. Common Stock Price Performance

NASDAQ SENS opened at $12.82 on Tuesday. The company has a market cap of $536.00 million, a PE ratio of -5.79 and a beta of 1.04. The firm’s 50-day simple moving average is $9.12 and its two-hundred day simple moving average is $7.26. Senseonics Holdings, Inc. Common Stock has a 52 week low of $4.79 and a 52 week high of $13.88. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last issued its quarterly earnings results on Monday, November 9th. The company reported ($0.50) EPS for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. The company had revenue of $19.56 million during the quarter. Research analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current year.

Insider Buying and Selling

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder acquired 13,953 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were purchased at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the acquisition, the director directly owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. The trade was a 8.87% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 4.70% of the company’s stock.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

A number of large investors have recently modified their holdings of SENS. StoneX Group Inc. purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the third quarter valued at approximately $128,000. Traynor Capital Management Inc. bought a new stake in Senseonics Holdings, Inc. Common Stock during the 3rd quarter valued at $152,000. State of Wyoming raised its holdings in Senseonics Holdings, Inc. Common Stock by 27.2% during the third quarter. State of Wyoming now owns 14,940 shares of the company’s stock worth $152,000 after purchasing an additional 3,199 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth approximately $36,000. Finally, Readystate Asset Management LP acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth about $574,000. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Senseonics Holdings, Inc. Common Stock News Summary

Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

Positive Sentiment: Senseonics raised its FY 2026 revenue guidance to $68 million–$70 million, up from $62 million–$66 million and above the $64.2 million consensus estimate. It also lifted its full-year gross-margin outlook to more than 60%. Third-quarter 2026 results
Positive Sentiment: Third-quarter revenue was about $19.6 million, up approximately 140% year over year, and exceeded analyst revenue estimates, highlighting strong sales growth. Q3 results and revenue estimates
Positive Sentiment: HC Wainwright reaffirmed its Buy rating and set a $14 price target. Raymond James also upgraded SENS, moving its rating from Underperform to Market Perform. HC Wainwright rating
Negative Sentiment: The company reported a third-quarter loss of $0.50 per share, slightly worse than the $0.49 consensus loss and wider than the $0.43 loss a year earlier. Quarterly earnings results

Senseonics Holdings, Inc. Common Stock Company Profile

(Get Free Report)

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.